Lipid profile among controlled and uncontrolled type-2 diabetic patients in a rural tertiary care center: a comparative study
Keywords:Blood glucose levels, Diabetes mellitus, Glycated haemoglobin, Lipid profiles
Background: Diabetes mellitus is one of the major health problem and endemic with rapidly increasing prevalence in both developed and developing countries. It has strong association with dyslipidaemias in relation to glycaemic control and duration of the disease. Dyslipidaemias make diabetic patients more susceptible to coronary artery disease (CAD) which is the major cause of increased mortality and morbidity. Objectives were to estimate the blood glucose levels and lipid profiles among diabetics and to compare the lipid profiles among controlled and uncontrolled diabetic subjects.
Methods: A cross sectional study was done including 100 diabetic subjects aged between 40 to 60 years of either sex. Patients were classified into 2 groups with 50 subjects in each group as per their glycemic index. Group 1 was controlled diabetic patients (HbA1c≤7.5%) and Group 2 was uncontrolled diabetic patients (HbA1c>7.5%). Venous blood samples were collected from the subjects. The serum was used for analyzing FBS, PPBS, HbA1c and lipid profiles.
Results: FBS, PPBS, HbA1c, total cholesterol, triglycerides and LDL were more in females than male patients but the mean values were not significant statistically except FBS and total cholesterol. All the lipid parameters were elevated among uncontrolled diabetic patients compared to controlled diabetic patients which was statistically significant.
Conclusions: Present study concluded that the blood glucose levels and lipid parameters were elevated among uncontrolled diabetics compared to controlled diabetics strongly depicting the co-relation between the glycemic levels and lipid abnormalities. Patients should be educated to monitor regularly and control blood glucose and lipid levels.
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999.
Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol. 2007;49:631-42.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Dia Care. 1998;21(9):1414-31.
Fall CHD. Non-industrialised countries and affluence relationship with type 2 diabetes. Br Med Bull. 2001;60:33-50.
Gupta V, Suri P. Diabetes in elderly patients. JK Pract. 2002;91(4):258-9.
Windler E. What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome? Atheroscler Suppl. 2005;6:11-4.
Basit A, Hydrie MZI, Hakeem R, Ahmedani MY, Masood Q. Frequency of chronic complications of type II Diabetes. J Coll Physic Surg Pak. 2004;14:79-83.
Toto RD. Heart disease in diabetic patients. Semin Nephrol. 2005;25:372-8.
Miller M. The epidemiology of triglyceride as a coronary artery disease risk factor. Clin Cardiol. 1999;22(6):S111-6.
The American Diabetes Association. Management of dyslipidemia in adults with diabetes. Dia Care. 1999;22(1):S56-9.
Khan HA, Clinical significance of HbA1C as a marker of circulating lipids in male and female type-2 diabetic patients. Acta Diabetol. 2007;44:193-200.
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosy-lated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421-31.
Krentz AJ. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab. 2003;5(1):S19-27.
Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Dia Care. 2005;28:514-20.
Eltigani MA, Barri AM, Bakhel K, Ibrahim M, Abbas A, Mudri M. Lipid profile abnormalities as predictive factor for electrocardiogram changes and coronary artery disease among Sudanese people in Shendi locality. Int Invent J Biochem. 2015;3:1-4.
Agarwal M, Patel JP, Lala MK. Association between glycemic control and serum lipid profile in known diabetic patients of civil hospital, Ahmedabad. Int J Med Sci Public Health. 2016;5:356-60.
Amer W, Zafar S, Majrooh A. Comparison of dyslipidemias in controlled and uncontrolled type 2 diabetics. Ann King Edward Med Coll. 2004;10:158-60.
Naheed T, Khan A, Masood G. Dyslipidaemias in Type 2 Diabetes Mellitus Patients in a Teaching Hospital of Lahore, Pakistan. Pak J Med Sci. 2003;19(4):283-6.
Pyorala K, Laakso S, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Dia Metab Rev. 1987;3(2):463-524.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34.
ndirakumari N, Vinutha S, Kambhar C. Study of lipid profile in diabetes mellitus patients who were on glibenclamide and glimeperide. IOSR J Dent Med Sci. 2015;14(1):13-22.
Nakhjavani M, Esteghamati AR, Heshmat FE. Dyslipidemia in type 2 diabetes mellitus: more atherogenic lipid profile in women. Acta Medica Iranica. 2006;44(2):111-8.
Barrett-Connor E, Giardina EG, Gitt AK, Gudat U, Steinberg HO, Tschoepe D. Woman and heart disease: The role of diabetes and hyperglycaemia. Arch Intern Med. 2004;164(9):9344-942.
Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: A meta analysis of prospective studies. Dia Care. 2000;23(7):962-8.
Kanaya A, Grady D. Barret-Connor E. Explaining the sex difference in coronary heart disease and mortality among patients with type- 2 Diabetes mellitus; A metaanalysis. Arch Interm Med. 2002;162(15):1737-45.